Regulatory Rapporteur - April 2025 | Regulatory Rapporteur

Regulatory Rapporteur – April 2025

Africa and the MENA region: Opportunities for growth

Clinical research in Africa: Regulatory environment, challenges and opportunities

A comprehensive analysis of drug pricing mechanisms and the regulatory framework in Morocco

Deciphering the regulatory landscape of MENA markets: Challenges in pricing and ancillary issues

Regulatory governance for medical research in the United Arab Emirates: A comprehensive overview

Essential steps for a successful notified body application in medical devices and in vitro diagnostic products

Making the move from regulatory affairs: Transferring your skills to the wider pharmaceutical industry

April 2025 – Contents
Africa and the MENA region: Opportunities for growth
Clinical research in Africa: Regulatory environment, challenges and opportunities
A comprehensive analysis of drug pricing mechanisms and the regulatory framework in Morocco
Deciphering the regulatory landscape of MENA markets: Challenges in pricing and ancillary issues
Regulatory governance for medical research in the United Arab Emirates: A comprehensive overview
Essential steps for a successful notified body application in medical devices and in vitro diagnostic products
Making the move from regulatory affairs: Transferring your skills to the wider pharmaceutical industry

Industry News

Rui Santos Ivo elected as new Chair of the EMA Management Board
Rui Santos Ivo has been elected as the new Chair of the European Medicines Agency (EMA) Management Board. Mr Santos Ivo takes over from Lorraine Nolan, who completed her tenure on 21 March 2025.
UK life science sector calls for more diverse workforce skills to secure future growth
To deliver cutting-edge treatments and revolutionise patient outcomes, the future life sciences sector workforce must be equipped with skills ranging from advanced scientific expertise, digital proficiency and AI-driven problem solving, according to a newly published report.
MHRA appoints new Chief Executive Officer
Lawrence Tallon has been appointed the new Chief Executive Officer at the Medicines and Healthcare products Regulatory Agency (MHRA) and will begin the role on 1 April 2025.

More news

Pharmacies told to follow GPhC guidance on prescription-only weight-loss medicine

Online pharmacies in England, Scotland and Wales are required to follow updated guidance from the General Pharmaceutical Council (GPhC), after concerns that prescription-only medicines (POM) for weight loss are being inappropriately supplied.